Cargando…
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
BACKGROUND: Development of chemo−/radioresistance is a major challenge for the current prostate cancer (CaP) therapy. We have previously demonstrated that epithelial cell adhesion molecule (EpCAM) is associated with CaP growth and therapeutic resistance in vitro, however, the role of EpCAM in CaP in...
Autores principales: | Ni, Jie, Cozzi, Paul, Beretov, Julia, Duan, Wei, Bucci, Joseph, Graham, Peter, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233586/ https://www.ncbi.nlm.nih.gov/pubmed/30419852 http://dx.doi.org/10.1186/s12885-018-5010-5 |
Ejemplares similares
-
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018) -
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
por: Gires, Olivier, et al.
Publicado: (2020) -
Epithelial Cell Adhesion Molecule (EpCAM) Expression Can Be Modulated via NFκB
por: Zia, Saadiya, et al.
Publicado: (2022)